Download presentation
Published byHilda Kelley Modified over 9 years ago
1
LSU Internal Medicine Case Conference “What the Bullae!" 10/02/2012
Jay Mansfield, MD PGY I Internal Medicine
2
“Worsening shortness of breath” x several months
Chief Complaint “Worsening shortness of breath” x several months
3
HPI 76 year-old African American woman with significant past medical history of ischemic cardiomyopathy s/p AICD (last EF <20% in 12/2011), hypertension, hyperlipidemia, CKD stage III, peripheral vascular disease s/p left SFA stent (3 weeks prior) with left foot ischemic toes and multiple ulcers presented to the ED complaining of progressively worsening shortness of breath and fatigue over the past several months. The patient started developing bilateral lower extremity edema and claudication.
4
HPI She also developed orthopnea – having to sleep upright in a chair.
She had previously been able to ambulate about 1½ blocks easily but now can only walk a few steps before becoming short of breath. She denied any chest pain, nausea, vomiting, fever or chills. The patient is not able to recall all her medications and reports that she has not been adherent with her medications.
5
Past History Past Medical History: Surgical History: As above plus
Hypothyroidism Surgical History: Hysterectomy ICD (2010) Left SFA stents (3 weeks prior)
6
Past History Allergies: Home Medications:
Penicillin/Sulfa swelling and rash Home Medications: Aspirin 81 mg Daily Clopidogrel 75 mg Daily Simvastatin 40 mg QHS Carvedilol mg BID Lantus 10 Units QHS NovoLog 5 Units BID Levothyroxine 50 mcg Daily Ondansetron 4 mg PO q8hrs prn nausea
7
Past History Family History Social History: NC
History of tobacco use >20 years previously with 5-pack year history No ETOH, no illicit drugs Lives alone Has three daughters who live close and visit frequently
8
Past History Health Maintenance: Review of Systems
PCP at LSU Medicine Clinic (Dr. Lacour) Up-to-date on Influenza and Tdap Unknown Pneumovax Mammogram WNL (1/2012) No colonoscopy Review of Systems Negative except per HPI
9
Vital Signs & Physical Exam
10
Vital Signs Temp 99° F Pulse 93 RR 20 BP 131/57 Pulse Ox 97% on RA
Weight 77 kg Height cm BMI
11
Physical Exam I General: HEENT: Neck: Cardiovascular:
AAOx3, no acute distress HEENT: NCAT, PERRL, EOMI, clear oropharynx Neck: Supple. No Carotid bruits. JVP 12 cm H2O Cardiovascular: Regular rate and rhythm. No murmurs or rubs.
12
Physical Exam II Pulmonary: Abdomen: Extremity:
CTA bilaterally, no wheezes/rhonchi/crackles Abdomen: Nondistended, bowel sounds present, soft , non tender, obese Extremity: Dorsalis pedis and Posterior tibial pulses not palpable. 2+femoral and radial pulses bilaterally. 2+ pitting edema bilaterally in lower extremities to lower back. 1+pitting edema in LUE. No palpable cords.
13
Physical Exam III Skin: Neurologic:
No rashs, no bruises. Left foot bandaged with multiple ischemic toes and wounds with purple stained skin from gentian violet preparation Neurologic: Face symmetric, tongue and uvula midline. Hearing grossly intact. Muscle strength 5/5 x 4 Decreased sensation to pain and light touch over lower extremities especially feet bilaterally
14
Laboratory Data Day of Admission
15
Admit Laboratory Data I
WBC 12.4 ( ) Hgb 12.4 Hct 39.7 PLT 161 MCV 74.8 (80-100) RDW 17.8 ( ) Seg 80% Bands 13% Lymphs 1% Monos 5% Basophils 1%
16
Admit Laboratory Data II
Na 136 K 4.5 Cl 104 Bicarbonate (24-32) BUN (7-25) Creatinine ( ) GFR 38 (>60) Glucose 239 (65-99) Ca 9.78 Mg Phos 3.4
17
Admit Laboratory Data III
Total Protein 6.8 Albumin ( ) Total Bilirubin (<1.3) AST Alkaline Phosphatase 114 ALT BNP (<100) TSH Free T
18
EKG Day of Admission
20
EKG First degree A-V block
Cannot rule out anterior myocardial infarction, age undetermined Low QRS voltage in limb leads No significant change from previous tracing
21
Chest X-Ray Day of Admission
24
CXR “Dual lead pacemaker again noted.
The cardiomediastinal silhouette is stable with calcifications of the aortic knob and four-chamber cardiac enlargement. Bronchovascular marking pattern is unchanged. There is no evidence of pulmonary edema. The lungs are clear. There is no focal airspace consolidation, pleural effusion, or evidence of pneumothorax. Again noted is osteopenia and thoracic kyphosis.”
25
Hospital Day 1
26
Initial Management Patient was admitted to Medicine
IV furosemide 40mg q12 hours initiated with strict I/O’s Home medications continued
27
Hospital Day #3 Patient was noted by Primary Care team to have developed multiple hemorrhagic bullae on her right lower extremity She was also noted to have altered mental status Medical ICU, General Surgery and Infectious Disease services were consulted Labs, cultures, and ABG were obtained Patient was placed on NRB Patient was empirically started on Vancomycin, Clindamycin, and Ciprofloxacin
28
Vital Signs Temp 97° F (96-99.9 ° F) Pulse 98 RR 20 BP 123/63
Pulse Ox 96% on 3L NC
29
Physical Exam I General: HEENT: Cardiovascular: Pulmonary: Abdomen:
Awake, lethargic, no acute distress HEENT: NCAT, PERRL, EOMI, clear oropharynx Cardiovascular: Regular rate and rhythm. No murmurs or rubs. Pulmonary: CTA bilaterally, diffuse expiratory wheezes present; no crackles, good air movement Abdomen: Nondistended, obese, bowel sounds present, soft , non tender
30
Physical Exam II Extremity: Skin:
2+ Radial pulses bilaterally. PT and DPs not palpable secondary to edema. 2+ pitting edema LE bilaterally to upper thighs. Left foot dressed in clean bandage. Multiple ischemic toes on Left foot. Skin: Multiple hemorrhagic bullae to anterior and medial aspect of RLE measuring 4x2cm. Posterior aspect of RLE near popliteal fossa where bullae erupted, weeping serosanguinous fluid with associated erythema and warmth.
31
Laboratory Data I Day #3 WBC 2.6 (4.5-11.0) Hgb 13.8 Hct 43.6
PLT ( ) MCV (80-100) RDW ( ) Seg 52% Bands 13% Lymphs 17% Monos 16% Basophils 1%
32
Laboratory Data II Day #3
Na 137 K 3.7 Cl 104 Bicarbonate (24-32) BUN 29 Creatinine ( ) GFR (>60) Glucose (65-99) Ca++ 7.99.66 Mg++ 1.5 Phos 3.4 Blood cultures pending ABG 7.45/40/235/28/100% on 100% NRB
33
Laboratory Data III Day #3
Total Protein ( ) Albumin ( ) Total Bilirubin (<1.3) AST Alkaline Phosphatase 58 ALT INR ( ) PT (9-12.7) PTT (24-37) Lactic Acid
34
Hospital Course: Day #3 Patient was given a total of 2 amps of D50 and some juice. Patient’s mental status returned to baseline. Repeat accucheck was 96. Patient underwent Ultrasound of right lower extremity – no DVT Patient was transferred to MICU for continued monitoring and management
35
Hospital Course: Day #3 Transfer Antibiotic Medications: Ciprofloxacin
Vancomycin Clindamycin Tigecycline
36
Hospital Course: Day #3 Patient’s bullae began to desquamate and increase in number: affected anterior thigh area measured 8x4cm, posterior fossa skin involvement measured ~12cm in length Patient had no mucosal involvement New bullae appeared on patient’s suprapubic area with notable erythema and extreme tenderness 4x2cm Right upper extremity became more edematous and extremely tender to touch, no bullae were noted, increased erythema noted in RUE antecubital fossa
37
Hospital Course: Day #3 Dermatology was consulted and performed bedside examination and punch biopsy of one of the bullae on patient’s right lower extremity
38
Hemorrhagic Bullae Suprapubic
39
Anterior Thigh Right Lower Extremity
40
Medial Right Lower Extremity
41
Lateral Right Lower Extremity
42
Right Upper Extremity
43
Hospital Course Morning Day #4
Patient stated she felt better. Patient only complaining of pain in right arm and right hand Oriented to person, place. Confused about exact date. Small bullae noted in RUE antecubital fossa measuring 0.5x0.5cm Other bullae and lesions appeared stable
44
Laboratory Data I Morning Day #4
WBC ( ) Hgb 12.9 Hct 40.1 PLT 111 ( ) Seg 71% Bands 8% Lymphs 13% Monos 8% Basophils 0%
45
Laboratory Data II Morning Day #4
Na 139 K 4.4 Cl 101 Bicarbonate BUN 31 (7-25) Creatinine 1.55 ( ) GFR 40 (>60) Glucose 92 Anion Gap 18 (<10) Ca++ 7.49.32 Mg++ 1.4 Phos 4.5
46
Laboratory Data III Day #3
Total Protein (6-8) Albumin ( ) Total Bilirubin (<1.4) AST (<45) Alkaline Phosphatase 44 ALT BNP 3923 (<100) Lactic Acid 4.2 ( )
47
Hospital Course: Day #4 Patient became hypotensive requiring pressor support with total of 2 pressors: Levophed and Vasopressin Patient became more altered and was intubated to protect her airway Patient’s UOP significantly declined despite being on a lasix drip Patient was transfused albumin to help with diuresis
48
Hospital Course: Day #4 X-Ray of Right Lower Extremity revealed extensive edema, no subcutaneous emphysema
49
Significant Laboratory Data Day #4
Lactic Acid 1.6 4.2 10.4 Bicarbonate 25 12 6 Creatinine 1.24 1.55 1.95 2.41 WBC 2.6 2.7 10.1 14.3 Bandemia 13% 27% 8% 35% Platelets 110 131 111 97 49 INR 2 3.9 PT 43.1 CK 608 CRP 16.9 Troponin 1.88
50
Cont….. Patient became bradycardic and hypotensive, then became pulseless Patient was resuscitated with chest compressions and epinephrine Patient’s family decided to make the patient DNR if another code were to occur Patient became hypotensive again despite pressor support and died
51
Microbiology and Pathology Results
52
7/9/12: Right upper thigh, punch biopsy
56
Microbiology and Pathology Results
Blood cultures obtained on day of transfer to MICU revealed Group A Streptococcus in two bottles Swab of right thigh lesion grew Group A Streptococcus Repeat blood cultures on day after transfer to MICU had no growth Right upper thigh punch biopsy revealed subepidermal vesicular dermatitis with thrombotic vasculopathy, autolysis, and numerous interstitial bacterial cocci
57
Streptococcal Toxic Shock Syndrome
Final Diagnosis Streptococcal Toxic Shock Syndrome
58
Thanks For Your Attention!
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.